Physician profile
Aaron R Block
NPI 1700922390
$1,322.31
in general payments reported to CMS, 2019-2025
22 companies · $82.28 in 2025
The $82.28 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.07 · 2022: $397 · 2023: $529 · 2024: $301 · 2025: $82.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $912.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $205.92 | 2022-2023 | Wegovy, Rybelsus, Ozempic |
| Eisai INC. | $189.98 | 2024-2025 | |
| Lilly USA, LLC | $176.98 | 2022-2024 | Mounjaro, Zepbound |
| Pfizer INC. | $134.16 | 2023-2024 | |
| Exact Sciences Corporation | $127.18 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $121.97 | 2022-2024 | Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.45 | 2022-2023 | Jardiance |
| Radius Health, INC. | $37.66 | 2023-2024 | Tymlos |
| Celgene Corporation | $30.77 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.31 | 2023 | Spravato |
| Abbott Laboratories | $25.16 | 2024 | Proclaim |
| Tactile Systems Technology INC | $23.06 | 2023 | Entre Plus, Flexitouch Plus |
| Gilead Sciences, INC. | $20.78 | 2022 | |
| Idorsia Pharmaceuticals US INC | $20.03 | 2023 | Quviviq |
| Lundbeck LLC | $19.71 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $19.30 | 2023 | Prolia, Evenity |
| Otsuka America Pharmaceutical, INC. | $17.68 | 2023 | Rexulti |
| Bausch Health US, LLC | $17.42 | 2022 | |
| Astellas Pharma US INC | $15.99 | 2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $14.30 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $13.07 | 2021 | |
| Currax Pharmaceuticals LLC | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Block listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.